Glaxosmithkline PLC, 10% Owner at Progyny, Inc. (PGNY), sold 4,000,000 shares at $25.75 ($103.0M) on 2020-05-20, disclosed to the SEC on 2020-05-21.
Open-market sale of $103.0M PGNY by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |